VPS33B and acute myeloid leukemia: We also confirmed that blocking EV maturation and secretion by acute myeloid leukemia (AML) cells through Vps33b knockout/knockdown suppressed AML cell growth and prolonged disease progression in both a mouse model and patient samples (17).